Foundation:

diabetes mellitus is a chronic disease. One of its frequent complications is the diabetic foot. For its treatment Heberprot-P is used.

Objective:

to describe the results of the application of Heberprot-P for the treatment of diabetic foot ulcer.

Methods:

prospective descriptive study conducted in the Diabetic Care Consultation, during the period from April 2009 to April 2016. The sample consisted of the 41 patients with diabetic foot ulcer older than 20 years, to whom the treatment with Heberprot-P. We analyzed: age, associated diseases, years of evolution of the disease, medication dose and healing.

Results:

female patients predominated (56.1%); the age group of 60-69 years (34.2%) and hypertension as an associated disease (48.8%); 43, 9% had an evolution of diabetes of 10-19 years; according to the Wagner classification, group III prevailed with 48.8% and II with 31.7%; 5 to 9 doses of Heberprot-P were applied in 43.5%. 78% achieved complete healing.

Conclusions:

in three quarters of patients with diabetic foot ulcer complete healing was achieved with the application of Heberprot-P therapy.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )